Logo image
Lopinavir-Ritonavir: Effects on Endothelial Cell Function in Healthy Subjects
Journal article   Open access   Peer reviewed

Lopinavir-Ritonavir: Effects on Endothelial Cell Function in Healthy Subjects

Jessica R. Grubb, André Dejam, Jocelyn Voell, William C. Blackwelder, Peter A. Sklar, Joseph A. Kovacs, Richard O. Cannon, Henry Masur and Mark T. Gladwin
The Journal of infectious diseases, v 193(11), pp 1516-1519
01 Jun 2006
PMID: 16652279
url
https://doi.org/10.5334/cstp.409View
Published, Version of Record (VoR)CC BY V4.0 Open

Abstract

To differentiate between the effects that antiretroviral drugs have on the endothelium and the secondary effects that they have on immune function, viral load, and dyslipidemia, 6 non–human immunodeficiency virus–infected human subjects were treated with lopinavir-ritonavir for 1 month and, on the basis of forearm blood flow, the treatment’s effects on endothelial cell function were measured. Surprisingly, after exposure to lopinavir-ritonavir, absolute forearm blood-flow responses to the endothelium-dependent vasodilator, acetylcholine, increased significantly (P=.03), and forearm blood flow decreased to a greater extent during specific inhibition of NO synthase by NG-monomethyl-l-arginine. Thus, in this small cohort of subjects, short-term treatment with lopinavir-ritonavir does not appear to directly promote endothelial cell dysfunction

Metrics

5 Record Views
30 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Web of Science research areas
Immunology
Infectious Diseases
Microbiology
Logo image